Preview Newsletter
Ethicon Media Monitoring 4/20/2017
-
Mesh Rally Plans Moving Ahead for New Jersey
Apr 20, 2017 | Mesh Medical Device Newsdesk
The time and place for a peaceful rally over Johnson & Johnson’s mesh implants is set for April 27, 2017, at the State Theater, 15 Livingston Ave. New Brunswick NJ. 9:15 am doors open. -
Mesh Trials Ahead with No Prospect of Settling
Apr 19, 2017 | Mesh Medical Device Newsdesk
Protracted transvaginal mesh (TVM) litigation has many law firms moving onto the next attractive Mass Tort and clearing out their inventory. -
What's your experience of vaginal mesh implants?
Apr 19, 2017 | The Guardian
...If you’ve received vaginal mesh implants, we’d like you to share your experiences with us. You can fill in the form – anonymously, if you prefer – and we’ll use a selection of responses in our reporting. -
NHS and manufacturers may have to pay out tens of millions over vaginal mesh implant claims
Apr 19, 2017 | Claims Magazine
By Marek Handzel
More than 800 women in the UK are taking legal action against the NHS and the manufacturers of vaginal mesh implants after suffering severe discomfort caused by the devices. -
Concerns over vaginal mesh implants
Apr 19, 2017 | WebMD UK Health News
By Peter Russell
Hundreds of women are reported to be suing the NHS because of severe pain and disability caused by vaginal mesh implants -
Hundreds of women take legal action over vaginal mesh implants
Apr 19, 2017 | OnMedica
By Ingrid Torjesen
More than 800 UK women are taking legal action against the NHS and the makers of vaginal mesh implants, which are used to treat pelvic organ prolapse and incontinence after childbirth. -
What Is Vaginal Mesh? Hundreds Of Women Suing Over Incontinence Treatment
Apr 19, 2017 | Huffington Post UK
By Rachel Moss
Hundreds of women are taking legal action against the makers of vaginal mesh implants, which are often used to teat pelvic organ prolapse or incontinence. -
1,000 women complain over
Apr 19, 2017 | Liverpool Echo
By Tom Belger
More than 1,000 complaints have been made about vaginal mesh implants, with one woman describing the mesh as cutting “like a cheese-wire”.
Client Attorney Privileged/Attorney Work Product/At Request of Counsel
Online Sources
-
Mesh Rally Plans Moving Ahead for New Jersey
Apr 20, 2017 | Mesh Medical Device Newsdesk
Mesh Medical Device News Desk, April 19, 2017 ~ The time and place for a peaceful rally over Johnson & Johnson’s mesh implants is set for April 27, 2017, at the State Theater, 15 Livingston Ave. New Brunswick NJ. 9:15 am doors open.
Johnson & Johnson plans its annual shareholders meeting on April 27 and women and their families from around the country are planning to converge outside of the State Theater to voice their concern over the company’s troubling products.
The shareholders meeting will be broadcast as a live webcast at www.investor,jnj.com under Webcasts & Presentations. It will remain available for three months.
The meeting will see the annual election of board directors. During the presentation, by CEO Alex Gorsky, they will listen to the operational sales growth and reports on shareholder returns.
Gorsky, the CEO since April 2011, receives an annual bonus set at 135% of target goals. Add that to direct compensation in 2016 and Gorsky received $22,228,019. The CEO has his pay aligned with company performance. There is no automatic or guaranteed annual salary increase.
Board members are compensated $200-$300,000. Their role is to provide independent oversight of management and the CEO. Alex Gorsky is CEO and Chair of the Board of Directors. There will be a proposal requiring the Chairman of the Board to be an independent director to minimize any potential conflict of interest. P. 88 Ultimately the decision will be made depending on what leadership structure serves the interests of J&J and its stakeholders.
Gorsky has been deposed to provide information on the Ethicon transvaginal mesh litigation in New Jersey. See the MND story here.
Shareholders of 2,710,891,992 shares of common stock can vote at the annual meeting. You can vote in advance www.proxyvote.com and follow instructions. Here are the J&J materials.
See the Facebook page for MAM (Mesh Awareness Movement) for rally information.
At the peaceful protest there will be a film crew chronicling the protest for a documentary based on Patient Safety. The rally expects to also see those whose lives have been affected by the J&J drug, Risperdal, Depuy Pinnacle Hip Implants, Power Morcellators, Levaquin, etc. for this event.
The film crew will also be conducting personal interviews from anyone who would like to participate in this documentary by sharing your personal experience.
There is a GoFundMe option to help defray costs from those in attendance. It is overseen by MAM.
Three years ago, mesh injured plaintiffs and their families gathered at the Boyd federal courthouse in Charleston, WV for the first peaceful protest of mesh manufacturers.
Johnson & Johnson’s Ethicon division has nearly 40,000 cases filed in that consolidated federal court.
There are another 10,000 filed in a state court in New Jersey as well as various state courts around the country and overseas in Ireland, Scotland, the UK, Israel, Australia etc. J&J/Ethicon remains the manufacturer with the largest numbers of product liability cases filed in the U.S.
Mr. Gorsky was the head of Janssen Pharmaceuticals when Risperdal, the antipsychotic, was sold to nursing homes and for use in children. It cased strokes in the elderly and caused boys to grow large breasts. Data was concealed while the marketing and market share grew with help of a sales force called ElderCare.
Eventually J&J got caught and paid more than $2 billion in penalties and settlements. The lawsuits continue but Risperdal brought J&J some $30 billion in sales, so overall is on the profitable side.
After a brief time with Novartis, he returned to J&J in 2008 to head the Ethicon medical device division. By 2009 Gorsky, became worldwide chair of medical devices and diagnostics.
Mr. Gorsky earned $25 million in 2014. ### ###
http://www.meshmedicaldevicenewsdesk.com/mesh-rally-plans-moving-ahead-new-jersey/
-
Mesh Trials Ahead with No Prospect of Settling
Apr 19, 2017 | Mesh Medical Device Newsdesk
Mesh Medical Device News Desk (MND), April 18, 2017~Protracted transvaginal mesh (TVM) litigation has many law firms moving onto the next attractive Mass Tort and clearing out their inventory.
What remains when the dust settles?
The online add for the publisher Harris Martin promises an upcoming legal education conference on hernia mesh, Benicar, Xarelto, testosterone drugs, and Bair Hugger – all the latest, shiniest Mass Torts that promise to deliver litigation lightning while reducing risk to the bottom line of plaintiffs’ law firm. Plaintiffs should make something too.
Meanwhile transvaginal mesh litigation, with about 150,000 U.S. plaintiffs, and thousands others overseas, lingers with the largest mesh makers the longest holdouts to the settlement table.
That was supposed to be the aim of the multidistrict litigation (MDL) where the bulk of transvaginal mesh cases, filed against seven manufacturers, are consolidated.
Try a few cases, see which way juries will decide and have that serve as a basis to approach some reasonable settlements in these defective product cases. But that hasn’t happened.
“The primary strategy by Ethicon and by C.R. Bard is to basically say you need money more than we do, you have no prospect unless you take what we offer now, and that’s offensive to me,” says New Jersey attorney Adam Slater.
He is based near the Bergen County court where transvaginal mesh cases will be heard in succession beginning at the end of this year and into next.
Slater says he is insulted by the offers.
“I won’t sit at a table with anyone who says that to me. They have to be reasonable, and what they’ve done is very serious, or else I will continue to prepare to ultimately get reasonable offers for my clients.”
Mazie Slater is one of the law firms still taking transvaginal mesh cases filed by women who claim a lifetime of injuries from the polypropylene implants used to treat incontinence and pelvic organ prolapse.
Slater says he doesn’t see an end to the litigation and adds, “I’m not going to stop.”
Here is a MND story on law firms that remain in TVM litigation.
TRIALS AHEAD
Linda Gross trial, Atlantic City NJ Feb 2013
For the remaining trial lawyers, litigating pelvic mesh cases will continue for years.
The next trial for C.R. Bard is in Bergen County, New Jersey by October 30th, and possibly sooner.
Slater says he is in full scale litigation against Bard with no prospects for settlement.
“Bard said you will never get to trial. I said “Watch me.””
Philadelphia’s Court of Common Pleas has 190 transvaginal mesh cases in line to be tried against defendants Boston Scientific and Ethicon/ Johnson & Johnson. Currently the Engleman v. Ethicon trial is underway.
April 18th, a Pelvic Mesh Meeting was scheduled.
**Update 11 new cases were set for trial as a result of yesterday’s meeting. All but two name Ethicon/ J&J, the other two name Boston Scientific as a defendant. See the schedule here.
In Philadelphia, six cases against Ethicon have a trial date certain. One naming Defendant Boston Scientific is set for March 2018. See the Pelvic Mesh Case list here.
Ethicon/ Johnson & Johnson, has proven to be a holdout, offering a smattering of settlements, particularly on individual cases just before trial. Instead, it quietly took its most troubling meshes off the market.
Boston Scientific too has proven to be tough defendant to bring to the negotiating table.
Mostyn Law is planning a trial against Boston Scientific to be heard in Los Angeles Superior Court, July 31, 2017. Six plaintiffs’s cases may be heard among the possible 247 filed. See JCCP 4733 here.
Another Ethicon/ Johnson & Johnson case is set for trial in Bergen Co. November 27, 2017 with a November 13th date set for jury selection.
Slater says his position with Ethicon is the same – No Prospect of Settling!
“I’m aware of the numbers offered. No way would I ever offer that to my clients,” he tells MND.
With 102,000 product liability cases naming seven mesh makers filed in Charleston, WV, consolidated in multidistrict litigation, there are an additional 1,000 cases naming C.R. Bard filed in New Jersey and another 9,000 naming Ethicon/ Johnson & Johnson in the same court. Some of those have settled.
AMS (American Medical Systems), sold to Endo International in 2011 and stopped making pelvic mesh one year ago. AMS/Endo agreed to a mass settlement of its transvaginal mesh cases. Because of that move, there was no discovery required to prepare for trial, therefore little evidence on which to base litigation.
Caldera Medical has offered about 2,700 women a dwindling amount of insurance money, about $11.75 million, the amount that remained after legal wrangling with its insurance carrier.
Those settlement packets of approximately $4,000 per plaintiff are currently being sent out. It does not include legal fees and expenses, which will cut the settlement dollars roughly in half.
WHEN SETTLING MAKES SENSE
The harsh truth is that most of the 102,000 cases filed in multidistrict litigation will never pass the threshold of the courtroom.
Many plaintiffs refuse to accept the amount of dollars offered in a settlement. When they retained a law firm it was often with the promise of a “million dollar case.”
That is a red flag as no one can promise you the outcome of your case. There are far too many variables, such as a jury, for example. But still, emotions run high when a promise made isn’t kept.
Of the cases tried, most have resulted in jury awards compensating them for pain and suffering, for past and future medical care, and punitive damages.
Then the appeals process begins, which can take years. About four cases that won at the trial level, have exhausted the appeals process and been paid to the plaintiff. Gross v. Ethicon, the first New Jersey case against Johnson & Johnson, is on the eve of paying its $11.1 million jury award after nearly four years of appeals by J&J.
So when do you accept a settlement? For many women settlements make a lot of sense.
If you have a mesh in place and for the present time, are still able to function, a settlement might make sense. A lawyer can structure an annuity so the money is doled out for a longer time and it’s tax free.
There is no waiting years for the appeals process to wind through the court.
There is an immense downside in going to trial that many plaintiffs do not consider. A woman’s life is on display including her most intimate pelvic problems, she lives away from home, maybe for months, must be deposed by lawyers for the mesh makers and probed in a pelvic exam done by doctors for defense. There is always some degree of public humiliation about her weight, or preexisting conditions or her sex life. And there is no telling what a jury will do.
But if you think you have no options but stay with your current law firm, think again.
“I’m hearing stories of women being threatened by their attorney that they will face a penalty if they talk to another law firm. It is unethical to make that threat under New Jersey law. The client owns the case, not the lawyer,” he tells Mesh News Desk. ###
http://www.meshmedicaldevicenewsdesk.com/mesh-trials-ahead-no-prospects-settling/
-
What's your experience of vaginal mesh implants?
Apr 19, 2017 | The Guardian
More than 800 women sue NHS and manufacturers over vaginal mesh implants. We’d like you to share your experiences of the procedure with us
More than 800 women are suing the NHS and the manufacturers of vaginal mesh implants after suffering serious complications.
Some women reported that the implants – used to treat incontinence after childbirth or pelvic organ prolapse, where the womb or bladder bulge against the walls of the vagina – had cut into their vaginas. One woman said she was left in so much pain that she considered suicide. Others have been left unable to walk or have sex, according to the BBC.
The medical regulator has said that the best current evidence supports the continued use of mesh implants to resolve health conditions that could themselves cause serious distress to patients.
If you’ve received vaginal mesh implants, we’d like you to share your experiences with us. You can fill in the form – anonymously, if you prefer – and we’ll use a selection of responses in our reporting.
Your responses are secure as the form is encrypted and only the Guardian has access to your contributions. We will do our best to keep you anonymous.
https://www.theguardian.com/society/2017/apr/19/whats-your-experience-of-vaginal-mesh-implants
-
NHS and manufacturers may have to pay out tens of millions over vaginal mesh implant claims
Apr 19, 2017 | Claims Magazine
By Marek Handzel
More than 800 women in the UK are taking legal action against the NHS and the manufacturers of vaginal mesh implants after suffering severe discomfort caused by the devices.
Between April 2007 and March 2015, more than 92,000 women had vaginal mesh implants fitted in England, according to NHS data obtained by the BBC’s Victoria Derbyshire programme. Women have the implants to treat pelvic organ prolapse and incontinence after childbirth. The data also shows that about one in 11 women has experienced problems with the mesh cutting into the vagina and causing severe discomfort. Some women have been left in permanent pain, unable to walk, work or have sex.
The claims could lead to the NHS paying out tens of millions of pounds.
Johnson & Johnson is the biggest maker of mesh implants, through its subsidiary company Ethicon. The BBC has obtained an email from the pharmaceutical company which suggests that it had suspected that it had problems with the implants as early as 2004. The email said the company needed to start a “major damage control offensive” because “the competition will have a field day”.
However, the US giant said that highlighting this email in isolation was “extremely misleading” and Ethicon, said it would “vigorously” defend any litigation.
The plastic meshes are made of polypropylene, which is the same material used to make certain drinks bottles and is manufactured by many different companies. There are around 100 types of vaginal mesh implants in the UK and not one model has been recalled to date.
Professor Carl Heneghan has told the BBC that manufacturers have to provide little evidence before their product is clinically approved and made available on the NHS. He said that manufacturers just have to provide documents that show their vaginal mesh implant is similar to one already on the market, after which it is highly likely to be approved.
The Medicines and Healthcare products Regulatory Agency (MHRA) says the use of vaginal mesh implants is safe and effective for the majority of women, The meshes are still prescribed on the NHS across the UK, although a recent review in Scotland concluded that they should not be routinely used for pelvic organ prolapse.
http://www.claimsmag.co.uk/2017/04/nhs-manufacturers-may-pay-tens-millions-vaginal-mesh-implant-claims/8602
-
Concerns over vaginal mesh implants
Apr 19, 2017 | WebMD UK Health News
By Peter Russell
Hundreds of women are reported to be suing the NHS because of severe pain and disability caused by vaginal mesh implants
The implants are used to treat urinary incontinence and pelvic organ prolapse after childbirth. However, some women have reported that the devices have perforated the lining of the vagina, leaving them in permanent pain, unable to walk or have sex.
The UK's medicines regulator says it "sympathises" with those affected.Legal action
According to the BBC's Victoria Derbyshire programme, more than 800 women in the UK are taking legal action against the NHS and the makers of vaginal mesh implants.
The meshes are made by different manufactures from a plastic called polypropylene. They are used to support organs such as the vagina, womb, bladder or urethra which may have been weakened while giving birth.
However, the programme found cases where surgery to implant them was followed by years of pain. One childminder described how the mesh had cut its way through the wall of her vagina "like a cheese-wire". Another woman said the pain had been so bad she had considered suicide.
The BBC quoted experts who said that if the women were successful in their legal claims, the NHS could be facing a pay-out amounting to tens of millions of pounds in compensation.
According to the Medicines and Healthcare products Regulatory Agency (MHRA), there were 733 'adverse incidents' in the UK for stress urinary incontinence and 346 for pelvic organ prolapse between 2012 and 2016.
Patient safety 'our highest priority'In a statement, an MHRA spokesperson says: "Patient safety is our highest priority and we sympathise with women who have suffered complications after surgery.
"We are committed to help address the serious concerns raised by some patients. We have undertaken a great deal of work to continuously assess findings of studies undertaken by the clinical community over many years, as well as considering the feedback from all sources in that time. What we have seen, and continue to see, is that the greater proportion of the clinical community and patients support the use of these devices in the UK for treatment of the distressing conditions of incontinence and organ prolapse.
We encourage anyone who suspects they have had a complication after having a mesh device implanted, to discuss this with their clinician and report to us via the Yellow Card scheme regardless of how long ago the implant was inserted."The meshes are still prescribed on the NHS in the UK. However, a review earlier this year in Scotland concluded that vaginal meshes should not be routinely offered to women with pelvic organ prolapse.
http://www.webmd.boots.com/urinary-incontinence/news/20170419/concerns-over-vaginal-mesh-implants
-
Hundreds of women take legal action over vaginal mesh implants
Apr 19, 2017 | OnMedica
By Ingrid Torjesen
More than 800 UK women are taking legal action against the NHS and the makers of vaginal mesh implants, which are used to treat pelvic organ prolapse and incontinence after childbirth.
Some women who have been given them have reported that the implants have cut into the vagina, causing severe discomfort, and interfering with their ability to have sex or even walk.
However, the medical regulator said that the best current evidence supports the continued use of mesh implants to resolve health conditions that could themselves cause serious distress to patients.
NHS data shows that between April 2007 and March 2015, more than 92,000 women had vaginal mesh implants in England. Data from the Medicines and Healthcare products Regulatory Agency (MHRA) for 2012 to 2017 show that there were 703 adverse incidents relating to patients who had been given the implants to treat stress urinary incontinence, where urine leaks when the bladder is under pressure. A further 346 adverse incidents were reported for patients who had been given a mesh support to prevent pelvic organ prolapse.
The MHRA told the BBC that that use of vaginal mesh implants is safe and effective for the majority of women. The meshes are still prescribed on the NHS across the UK, although a recent review in Scotland said they should not be routinely used for pelvic organ prolapse.
In the US, thousands of women have sued manufacturers, receiving payouts that total several billion dollars.
http://www.onmedica.com/newsArticle.aspx?id=5f2613d2-ebdd-4f76-89a8-9b352f14f53d
-
What Is Vaginal Mesh? Hundreds Of Women Suing Over Incontinence Treatment
Apr 19, 2017 | Huffington Post UK
By Rachel Moss
Hundreds of women are taking legal action against the makers of vaginal mesh implants, which are often used to teat pelvic organ prolapse or incontinence.
According to a report by the BBC’s Victoria Derbyshire programme, more than 800 women claim the treatment has caused them discomfort and in some cases, damaged their health.
The treatment is common in the UK, with more than 92,000 women receiving a vaginal mesh implant between April 2007 and March 2015 in England alone.- ADVERTISEMENT -
But what are vaginal mesh implants and, in light of the recent news, should women who currently have them be worried?What is a vaginal mesh implant?
A vaginal mesh implant, sometimes referred to as a sling implant, is a treatment given to women who experience pelvic organ prolapse and incontinence.
According to the NHS, pelvic organ prolapse is the bulging of one or more of the pelvic organs into the vagina. These organs are the uterus, vagina, bowel and bladder.
Although pelvic organ prolapse isn’t life-threatening, it can affect your quality of life by causing problems passing urine, leaking urine when you cough or sneeze, or difficulty having sex.
If other treatments - such as pelvic floor exercises - have been unsuccessful in treating symptoms, doctors may recommend a woman has a vaginal mesh implanted to support the vaginal wall and/or internal organs.
“A vaginal mesh is purely a synthetic net material used in the placement of a weak connective tissue or ligaments, suspending the vagina and uterus,” consultant gynecologist and obstetrician Dr Amed Ismail, from Queensway Gynecology Clinic, told The Huffington Post UK.
The mesh is implanted via a simple operation where the where the vagina is opened at the vaginal wall and the mesh is secured in place.
“This allows the angle between the urethra and the bladder to be a better shape to allow the woman to be continent rather than incontinent,” Dr Ismail said. Who receives vaginal mesh implants?
According to Dr Ismail, the majority of women who receive the treatment are over the age of 50, as weak connective tissue or ligaments around the pelvic organs can often be restored in younger women through lifestyle changes and pelvic floor exercises.
“Usually it’s for women who’ve had several children or, if they’ve only had one child: they’re probably overweight, have had a vaginal tear or never did any exercise during pregnancy or after having a baby,” he said.
The risk of pelvic floor prolapse and associated incontinence is also increased with being overweight, having a particularly difficult childbirth (such as long labour) and long-term coughing (for example, if you’re a smoker). What are the complications?
The Victoria Derbyshire programme spoke to women who claim they’ve experienced severe pain due to the mesh treatment, leaving them unable to walk, work or have sex.
According to Dr Ismail, such complications are usually caused by the mesh eroding, breaking down into smaller pieces which potentially move.
“The vagina area being stitched up is a weak point of the vaginal wall,” he said.
“The mesh can find it’s own way through this weak point and protrude outside the vagina.”
He said women may become aware of erosion if they feel discomfort during sex or if their partner can feel the mesh during sex.
Women who experience erosion of vaginal mesh may need to have a second operation in order to have the mesh removed or fixed.
However, Dr Ismail stressed that erosion of vaginal mesh is rare, claiming just 10% of women who have the treatment experience it. Should women be worried?
In a statement, the Medicines and Healthcare products Regulatory Agency (MHRA), said it is addressing concerns raised by patients in light of the BBC report, but it still supports the use of the treatment.
“We have undertaken a great deal of work to continuously assess findings of studies undertaken by the clinical community over many years, as well as considering the feedback from all sources in that time,” it said, according to PA.
“What we have seen, and continue to see, is that evidence supports and the greater proportion of the clinical community and patients support the use of these devices in the UK for treatment of the distressing conditions of incontinence and organ prolapse in appropriate circumstances.
“We encourage anyone who suspects they have had a complication after having a mesh device implanted to discuss this with their clinician and report to us via the Yellow Card scheme regardless of how long ago the implant was inserted.”
Dr Ismail reassured patients that the majority of women should not be worried “at all”.
“If they are asymptomatic, just leave them [the mesh] alone,” he said.
“If they are happy and are continent and are able to control urination, they’ve had a successful operation and that is fantastic news - 90% of people are like that.
“Anyone reading the news might think 90% of the women have the complication and 10% get better, but it’s the other way around.”
Anyone concerned after receiving a vaginal mesh implant should visit their GP or a healthcare professional.
http://www.huffingtonpost.co.uk/entry/what-is-vaginal-mesh-incontinence-treatment-risks_uk_58f71cdde4b05b9d613e6bda
-
Apr 19, 2017 | Liverpool Echo
By Tom Belger
More than 1,000 complaints have been made about vaginal mesh implants, with one woman describing the mesh as cutting “like a cheese-wire”.
The implants are a form of treatment for women who suffer incontinence and pelvic organ prolapse after having children, with at least 92,000 patients given them in the past decade.
But many women have blamed the implants for serious pain or discomfort while walking or having sex, with a Scottish inquiry concluding last year they should not be routinely offered to women for pelvic prolapse.
Several women shared their horror stories on the BBC’s Victoria Derbyshire programme as it revealed more than 800 women plan to sue the NHS or makers of the devices.
Kate Langley said a surgeon could see the tape of the mesh wire protruding through her vagina when she was examined after the pain became intolerable.
She called the implants “barbaric”, adding: “The mesh had cut its way through - like a cheese-wire.”
She said she had been to hospital more than 50 times over her problems, but it was reported the mesh could not be completely removed as it was near to a nerve.
Other women said the implants had injured their partners while having sex.
Claire Cooper, another patient, said she had considered taking her own life, and it had seriously affected her relationship.
She said: “We haven’t had sex for four-and-a-half years. This stuff breaks up marriages.
“I want the procedure banned. I want the material banned.”
But none of the 100 kinds of implant currently available have been recalled in Britain.
Ethicon, part of the pharmaceutical firm Johnson & Johnson, is a major mesh implant manufacturer, and is defending itself against legal action by patients.
A statement read: “Patient safety is our first priority.
“We empathise with all women suffering from pelvic organ prolapse and stress urinary incontinence, and are always concerned when a patient experiences an adverse medical event.
“TVT, TVT-O and Prolift were developed by surgeons seeking to address the shortcomings of other treatment options for stress urinary incontinence and pelvic organ prolapse.
“As other devices emerged, Ethicon continued to work in conjunction with doctors to provide them with additional options.
“These devices have helped millions of women suffering from stress urinary incontinence and pelvic organ prolapse.
“The success experienced by the vast majority of women who have been helped by these devices mirrors the scientific data and demonstrates that the devices should remain available as options for women, and their healthcare providers, who could benefit from their use in the future.”
http://www.liverpoolecho.co.uk/news/liverpool-news/1000-women-complain-over-cheese-12913025
Client Attorney Privileged/Attorney Work Product/At Request of Counsel
Online Sources
Add recipients
Suggested